WHG
APTO

Westwood Holdings Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Westwood Holdings Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-167
Closed -$448K – 491
2021
Q1 		$448K Hold
167
– – ﹤0.01% 387
2020
Q4 		$329K Hold
167
– – ﹤0.01% 389
2020
Q3 		$450K Buy
167
+18
+12% +$44.9K 0.01% 356
2020
Q2 		$423K Hold
149
– – 0.01% 364
2020
Q1 		$398K Hold
149
– – 0.01% 359
2019
Q4 		$380K Buy
+149
New +$194K ﹤0.01% 406

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Westwood Holdings Group's APTO Position: Q2 2021 in Review

Westwood Holdings Group sold out of Aptose Biosciences, Inc. (APTO) in Q2 2021, closing a stake of 167 shares — an estimated $448K sold.

Westwood Holdings Group first reported a position in APTO in Q4 2019 and held it in 6 quarters. The position peaked at $450K in Q3 2020. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.

  • Westwood Holdings Group reported no remaining Aptose Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Westwood Holdings Group sold 167 Aptose Biosciences, Inc. shares in Q2 2021, an estimated $448K.
  • Westwood Holdings Group first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 6 quarters.
  • Westwood Holdings Group's Aptose Biosciences, Inc. position peaked at $450K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2021.

Based on Westwood Holdings Group's 13F filing for Q2 2021, filed 16 Aug 2021.